PHE News

Philipson in Forbes: "If It Ain't Broke, Don't Fix It"

In Tomas Philipson's latest commentary for Forbes.com, he discusses pharmaceutical innovation and the recent open letter by the UAEM.

READ MORE

Precision's Chung, MacEwan, and Goldman in Health Affairs Blog: "One Size Fits All?"

Precision's Adrienne Chung, Joanna MacEwan, and Dana Goldman address formulary policy.

READ MORE

Lakdawalla in AP's The Big Story: "A Model for More Rational Drug Prices"

Darius Lakdawalla discusses the need for a more rational drug pricing model in a Q&A with Mathhew Perrone.

READ MORE

PHE's Goldman in Modern Healthcare: Take A Lesson From Vaccines

In Dana Goldman's latest commentary for Modern Healthcare, he suggests improving access and pricing for generics could be accomplished by taking a lesson from vaccine policy.

READ MORE
 
  • Academic Insights at

    the Speed of Business

     
  • Intellectual Integrity

    Led by professors at elite research universities, we bring intellectual integrity, academic rigor, and a creative approach to the most challenging problems in heath care.

     
  • Real World Impact

    PHE recommendations have defined and changed national and international payment policies.

     
  • Unparalleled Influence

    We frequently appear in top-tier publications and media outlets-- our work reaches top decision makers and influences outcomes.

     
  • Evidence Generation and

    Commercial Excellence

    As part of Precision for Value, our academic approach to research can be linked with a tailored, commercial approach that demonstrates the value of innovative medications.

     
  • Academic Insights at

    the Speed of Business